Orbimed Advisors LLC’s Edwards Lifesciences Corp Position
Does Orbimed Advisors LLC own Edwards Lifesciences Corp (EW)? Yes — 1.23M shares worth $99M (+1.95% of its 13F portfolio) as of Q1 2026, down from 1.84M shares the prior filed quarter.
Position Value
$99M
Q1 2026
Shares
1.23M
% of Portfolio
+1.95%
Quarters Held
25
currently held
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.23M | $99M | +1.95% |
| Q4 2025 | 1.84M | $157M | +3.21% |
| Q3 2025 | 1.68M | $131M | +3.08% |
| Q2 2025 | 1.71M | $134M | +3.34% |
| Q1 2025 | 1.53M | $111M | +2.65% |
| Q4 2024 | 1.15M | $85M | +1.74% |
| Q2 2023 | 515.0K | $49M | +0.88% |
| Q1 2023 | 630.0K | $52M | +1.02% |
| Q4 2022 | 860.5K | $64M | +1.23% |
| Q3 2022 | 966.3K | $80M | +1.48% |
| Q2 2022 | 1.01M | $96M | +1.74% |
| Q1 2022 | 1.05M | $124M | +2.01% |
| Q4 2021 | 1.08M | $139M | +1.79% |
| Q3 2021 | 1.13M | $128M | +1.40% |
| Q2 2021 | 1.13M | $117M | +1.18% |
| Q1 2021 | 1.13M | $94M | +0.88% |
| Q4 2020 | 1.03M | $94M | +0.82% |
| Q3 2020 | 706.5K | $56M | +0.71% |
| Q2 2020 | 530.4K | $37M | +0.52% |
| Q1 2020 | 176.8K | $33M | +0.56% |
| Q4 2019 | 434.9K | $101M | +1.45% |
| Q3 2019 | 507.8K | $112M | +2.12% |
| Q2 2019 | 715.0K | $132M | +2.05% |
| Q1 2019 | 715.0K | $137M | +2.12% |
| Q4 2018 | 465.6K | $71M | +1.32% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of EW.